NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-17.69	Insider Own	0.20%	Shs Outstand	76.46M	Perf Week	-11.48%
Market Cap	3.94B	Forward P/E	7.61	EPS next Y	6.06	Insider Trans	-25.08%	Shs Float	75.90M	Perf Month	-2.72%
Income	-1317.60M	PEG	-	EPS next Q	5.18	Inst Own	43.80%	Short Float	18.83%	Perf Quarter	-42.30%
Sales	1.40B	P/S	2.81	EPS this Y	-222.50%	Inst Trans	0.73%	Short Ratio	3.07	Perf Half Y	-77.02%
Book/sh	0.85	P/B	54.27	EPS next Y	-73.56%	ROA	-49.10%	Target Price	158.67	Perf Year	-69.43%
Cash/sh	-	P/C	-	EPS next 5Y	0.00%	ROE	-572.50%	52W Range	41.33 - 277.80	Perf YTD	-67.76%
Dividend	-	P/FCF	-	EPS past 5Y	-2.50%	ROI	-	52W High	-83.39%	Beta	1.43
Dividend %	-	Quick Ratio	1.00	Sales past 5Y	136.90%	Gross Margin	98.90%	52W Low	11.61%	ATR	6.00
Employees	1541	Current Ratio	1.00	Sales Q/Q	57.40%	Oper. Margin	-90.40%	RSI (14)	41.76	Volatility	10.89% 13.39%
Optionable	Yes	Debt/Eq	6.75	EPS Q/Q	184.00%	Profit Margin	-93.90%	Rel Volume	0.67	Prev Close	46.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 09 AMC	Payout	-	Avg Volume	4.65M	Price	46.13
Recom	2.10	SMA20	-11.19%	SMA50	-24.16%	SMA200	-66.24%	Volume	3,131,586	Change	-0.88%

May-20-22

Initiated

BofA Securities

Underperform

$35

Feb-23-22

Reiterated

B. Riley Securities

Buy

$315 → $265

Feb-22-22

Resumed

Jefferies

Buy

$198

Jan-21-22

Initiated

Cowen

Outperform

$150

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

May-25-22 06:00AM	Better Buy Ahead of FDA Meetings: Moderna vs. Novavax Motley Fool
May-24-22 12:01PM	Is Novavax Stock A Sell After Its First Covid Vaccine Quarter Misses Projections? Investor's Business Daily -9.46%
11:54AM	Why Novavax Stock Is Tumbling Today Motley Fool
05:21AM	3 Deeply Discounted Stocks You'll Wish You Bought on the Dip Motley Fool
May-21-22 06:08AM	Better Buy: Moderna or Novavax? Motley Fool
May-20-22 12:08PM	Novavax stock drops after BofA's bearish call MarketWatch -8.57%
12:01PM	Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding Motley Fool
10:43AM	Novavax Gets First Sell Rating Since 2020. Its Got a Covid Vaccine Problem, Analyst Says. Barrons.com
06:30AM	7 Growth Stocks to Avoid Until the Market Crashes Again InvestorPlace
May-19-22 06:40AM	3 Oversold Biotech Stocks to Buy Now InvestorPlace +12.13%
06:30AM	Will Novavax Stock Ever Reach Its All-Time High Again? Motley Fool
05:06AM	4 Growth Stocks Billionaire Money Managers Piled Into During the First Quarter Motley Fool
May-18-22 06:00AM	Could Novavax's Next Step Make It a Multibagger? Motley Fool
May-13-22 02:08PM	Biden Says US Ready To Share COVID-19 Vaccine Related Technology Benzinga +8.15%
12:19PM	Health Check: How Prudently Does Novavax (NASDAQ:NVAX) Use Debt? Simply Wall St.
11:00AM	3 Reasons That Novavax Investors Could Be Looking For The Door Motley Fool
10:57AM	Avoid Novavax Stock as Its Hopes Dwindle InvestorPlace
10:00AM	This Is the Most Important Number From Novavax's Q1 Earnings Motley Fool
May-11-22 06:30AM	This 1 Thing Could Make Novavax a Vaccine Leader Motley Fool -20.31%
May-10-22 02:47PM	Novavax (NVAX) Down on Q1 Earnings and Sales Lagging Estimates Zacks
11:51AM	Novavax Crashes As Alternative To Pfizer, Moderna Covid Shots Lags Estimates Investor's Business Daily
10:59AM	Novavax Stock Falls as Profit and Sales Badly Trail Estimates Barrons.com
10:39AM	Why Novavax Stock Is Sinking Today Motley Fool
10:22AM	Former global leaders urge U.S. to commit $5 billion to global COVID battle, urge Biden to take more forceful role at Thursday summit MarketWatch
09:47AM	Novavax posts first profitable quarter amid global COVID-19 vaccine rollout Yahoo Finance Video
08:29AM	Novavax shares slide 20% on COVID vaccine demand uncertainty Reuters
05:51AM	Novavax Missed Q1 Estimates By a Mile: Should Investors Worry? Motley Fool
05:06AM	Stock Market Plunge: 5 Discounted Growth Stocks to Buy Now and Hold Forever Motley Fool
03:51AM	Novavax, Peloton, Upstart Slump Premarket; Vroom, Biohaven Soar Investing.com
May-09-22 05:35PM	Novavax (NVAX) Q1 Earnings and Revenues Lag Estimates Zacks -7.05%
04:29PM	Novavax posts first quarterly profit, but misses expectations MarketWatch
04:28PM	UPDATE 2-Novavax 2022 COVID vaccine deliveries off to slow start, shares drop Reuters
04:08PM	Novavax reports 'first profitable quarter' amid Covid-19 vaccine work, but misses revenue forecasts American City Business Journals
04:02PM	Novavax Reports First Quarter 2022 Financial Results and Operational Highlights PR Newswire
07:05AM	Could Novavax Stock Help You Retire a Millionaire? Motley Fool
May-07-22 05:06AM	Nasdaq Bear Market: 3 Jaw-Dropping Growth Stocks You'll Regret Not Buying on the Dip Motley Fool
May-06-22 08:52AM	Is a Surprise Coming for Novavax (NVAX) This Earnings Season? Zacks
05:50AM	Why Novavax Is Crushing It This Week Motley Fool
May-05-22 08:15AM	Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates Zacks -6.49%
May-04-22 08:55PM	Ligand Pharmaceuticals (LGND) Q1 Earnings Lag Estimates Zacks +6.52%
05:14PM	Novavax files for authorization of COVID-19 shot among adolescents in Britain Reuters
04:02PM	Novavax to Participate in BofA Securities 2022 Healthcare Conference PR Newswire
02:25PM	Vaccine Makers Slump as Moderna, Pfizer Leave Full-Year Guidance Intact Bloomberg
10:11AM	Moderna CEO talks huge earnings beat, COVID-19 vaccine sales, new boosters Yahoo Finance Video
09:57AM	Why Is Novavax Stock Rising This Week? InvestorPlace
May-03-22 07:32PM	This Analyst Says to Be Positive About Novavaxs Covid Vaccine Chances TipRanks +9.56%
01:15PM	Novavax (NVAX) to Report Q1 Earnings: What's in the Cards? Zacks
07:49AM	The Window of Opportunity Has Closed for Novavax InvestorPlace
06:40AM	Novavax (NVAX) Surges 19.3%: Is This an Indication of Further Gains? Zacks
May-02-22 04:02PM	Novavax to Host Conference Call to Discuss First Quarter 2022 Financial Results and Operational Highlights on May 9, 2022 PR Newswire +19.26%
03:00PM	Novavax (NVAX) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks
11:56AM	Why Novavax Stock Is Soaring Today Motley Fool
11:10AM	Is a Beat in Store for Zoetis (ZTS) This Earnings Season? Zacks
09:48AM	Pfizer COVID-19 pill fails as preventive therapy in trial Yahoo Finance Video
Apr-29-22 08:51PM	Can Novavax Rebuild Investor Confidence? Analyst Weighs In TipRanks
05:45PM	Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
04:05PM	Novavax Surges As Its Covid Shot Approaches The FDA Finish Line Investor's Business Daily
11:38AM	The FDA has a meeting scheduled to review Novavaxs Covid vaccine. Heres what that means. American City Business Journals
11:19AM	Why Novavax Stock Is Soaring Today Motley Fool
11:07AM	FDA Announces Vaccines and Related Biological Products Advisory Committee Review of Novavax' COVID-19 Vaccine PR Newswire
10:30AM	San Franciscoarea transit system reinstates face-mask mandate, and FDA committee is set to review Novavax vaccine in June MarketWatch
09:42AM	FDA advisory committee to review Novavax's COVID-19 vaccine candidate in June MarketWatch
Apr-28-22 03:33PM	COVID-19: Moderna asks FDA to authorize vaccine for young kids, Merck antiviral pill sales top $3B Yahoo Finance Video
Apr-27-22 05:01PM	Former U.S. Surgeon General talks Faucis pandemic comments, COVID vaccines for kids, mask mandates Yahoo Finance Video
03:20PM	Novavax Stock Is Now Speculative, But it Still Has a Shot InvestorPlace
10:53AM	This Could Spell Bad News for Novavax Motley Fool
09:15AM	Novavax Could Get Analyst Downgrades Leading Up to Earnings InvestorPlace
09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? Zacks
06:15AM	7 Biggest Loser Stocks That Could Become Surprising Buys InvestorPlace
06:00AM	Does This News From Novavax Mean Trouble for Moderna? Motley Fool
05:52AM	Down 80% From Its High, Is Novavax Stock a Smart Buy Now? Motley Fool
Apr-25-22 01:24PM	Novavax (NVAX) Starts COVID-19 Booster Study in Adolescents Zacks +7.63%
Apr-22-22 04:00PM	The FDA Will Soon Give These 3 Healthcare Companies the Green Light Motley Fool
07:50AM	Novavax Starts Dosing In COVID-19 Booster Trial In Participants Aged 12 - 17 Years Benzinga
07:00AM	Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 Trial PR Newswire
Apr-21-22 11:58AM	Novavax (NVAX) Posts Upbeat Data on COVID/Flu Combo Jab Study Zacks -9.11%
09:40AM	Is Novavax Stock in Trouble? Motley Fool
09:24AM	Novavax nears FDA advisory meeting date Yahoo Finance
07:09AM	Novavax Just Reported Positive Initial Data for First Covid and Flu Shot. Its Stock Is Falling. Barrons.com
06:30AM	Is It Too Late to Buy Novavax Stock? Motley Fool
06:10AM	Novavax Stock Is Down Despite Positive Initial Data for First Covid and Flu Shot Barrons.com
Apr-20-22 05:27PM	Why Novavax Stock Fell Today Even After Good News Motley Fool
02:36PM	Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine PR Newswire
12:43PM	Novavax's experimental Covid-flu combo vaccine just got a boost American City Business Journals
12:41PM	Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine PR Newswire
12:40PM	Novavax publishes positive initial data for first combined Covid and flu vaccine Financial Times
11:42AM	Novavax's Covid-Flu Combination Vaccine Has "Potential Path Forward" Investing.com
Apr-19-22 11:26PM	Japan approves Novavax as fourth COVID-19 vaccine amid new surge MarketWatch
05:45PM	Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know Zacks
07:15AM	Novavax Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan PR Newswire
07:15AM	Novavax Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan CNW Group
04:13AM	Novavax stock continues its monthslong slide even after COVID vaccine earns approval in another country Fortune
Apr-18-22 01:39PM	Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today Motley Fool -5.79%
11:22AM	Novavax Is Down By 6%, Here Is Why FX Empire
10:27AM	Novavax Covid Vaccine On the Verge of Approval in Japan, Reports Nikkei Asia Investing.com
10:13AM	Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases PR Newswire
10:00AM	What Volatility in Novavax Means for Investors InvestorPlace
09:35AM	Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious Diseases CNW Group
08:52AM	UPDATE 1-Japan health ministry panel approves Novavax's COVID-19 vaccine Reuters
07:05AM	Is Novavax Stock a Buy Now? Motley Fool

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
YOUNG JAMES F	Director	Mar 31	Sale	73.58	12,500	919,765	62,590	Apr 04 05:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Option Exercise	19.08	5,000	95,400	8,845	Jan 05 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Sale	140.91	5,000	704,534	3,845	Jan 05 05:22 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	25.60	3,750	96,000	78,840	Jan 04 05:04 PM
YOUNG JAMES F	Director	Dec 31	Sale	144.16	3,750	540,601	75,090	Jan 04 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Option Exercise	19.08	5,000	95,400	8,845	Dec 22 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Sale	230.00	5,000	1,150,000	3,845	Dec 22 05:03 PM
Glenn Gregory M	President, R&D	Dec 15	Option Exercise	34.82	1,686	58,714	7,349	Dec 16 05:15 PM
Glenn Gregory M	President, R&D	Dec 15	Sale	174.13	1,686	293,584	5,663	Dec 16 05:15 PM
DOUGLAS RICHARD	Director	Dec 13	Option Exercise	25.60	1,500	38,400	33,450	Dec 15 05:22 PM
Glenn Gregory M	President, R&D	Dec 07	Option Exercise	19.08	8,250	157,410	12,311	Dec 09 05:20 PM
Glenn Gregory M	President, R&D	Dec 07	Sale	170.14	8,250	1,403,631	4,061	Dec 09 05:20 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Option Exercise	19.08	5,000	95,400	7,760	Dec 03 06:30 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Sale	196.19	5,000	980,944	2,760	Dec 03 06:30 PM
Glenn Gregory M	President, R&D	Nov 30	Option Exercise	19.08	8,250	157,410	13,003	Dec 02 04:13 PM
Glenn Gregory M	President, R&D	Nov 30	Sale	203.20	8,942	1,817,000	4,061	Dec 02 04:13 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Option Exercise	19.08	5,000	95,400	7,760	Dec 01 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Sale	228.72	5,000	1,143,600	2,760	Dec 01 05:02 PM
Glenn Gregory M	President, R&D	Nov 26	Option Exercise	5.95	3,460	20,587	6,144	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 26	Sale	218.07	2,083	454,247	4,061	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 23	Option Exercise	19.08	8,250	157,410	12,311	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 23	Sale	199.50	8,250	1,645,914	4,061	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 16	Option Exercise	19.08	8,250	157,410	12,311	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 16	Sale	169.48	8,250	1,398,180	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Option Exercise	37.90	1,183	44,832	5,244	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Sale	172.02	1,183	203,496	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 09	Option Exercise	19.08	8,250	157,410	12,311	Nov 12 05:02 PM
Glenn Gregory M	President, R&D	Nov 09	Sale	167.53	8,250	1,382,160	4,061	Nov 12 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Option Exercise	19.08	5,000	95,400	7,760	Nov 05 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Sale	200.00	5,000	1,000,000	2,760	Nov 05 05:02 PM
Glenn Gregory M	President, R&D	Nov 02	Option Exercise	19.08	8,250	157,410	12,311	Nov 04 05:22 PM
Glenn Gregory M	President, R&D	Nov 02	Sale	183.82	8,250	1,516,552	4,061	Nov 04 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Option Exercise	19.08	5,000	95,400	7,760	Nov 03 04:49 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Sale	163.08	5,000	815,422	2,760	Nov 03 04:49 PM
Glenn Gregory M	President, R&D	Oct 29	Sale	148.34	680	100,871	4,061	Nov 02 07:02 PM
Glenn Gregory M	President, R&D	Oct 26	Option Exercise	15.20	11,712	178,009	14,395	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 26	Sale	132.73	10,334	1,371,667	4,061	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 19	Option Exercise	19.08	8,250	157,410	12,311	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 19	Sale	165.14	8,250	1,362,427	4,061	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 15	Option Exercise	37.90	1,183	44,832	5,244	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 15	Sale	170.00	1,183	201,110	4,061	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 12	Option Exercise	19.08	8,250	157,410	12,311	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 12	Sale	163.18	8,250	1,346,218	4,061	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 05	Option Exercise	19.08	8,250	157,410	12,311	Oct 07 05:18 PM
Glenn Gregory M	President, R&D	Oct 05	Sale	174.41	8,250	1,438,895	4,061	Oct 07 05:18 PM
Erck Stanley C	President and CEO	Oct 04	Option Exercise	27.45	42,829	1,175,583	66,708	Oct 05 05:05 PM
Erck Stanley C	President and CEO	Oct 04	Sale	176.15	42,829	7,544,195	23,879	Oct 05 05:05 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Option Exercise	19.08	5,000	95,400	7,760	Oct 05 05:02 PM
Erck Stanley C	President and CEO	Oct 01	Option Exercise	27.17	49,000	1,331,400	72,879	Oct 05 05:04 PM
Erck Stanley C	President and CEO	Oct 01	Sale	175.10	49,000	8,580,064	23,879	Oct 05 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Sale	174.89	5,000	874,452	2,760	Oct 05 05:02 PM
Glenn Gregory M	President, R&D	Sep 30	Sale	207.25	693	143,622	4,061	Oct 01 05:58 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Sale	209.92	7,501	1,574,637	2,546	Sep 29 05:06 PM
Glenn Gregory M	President, R&D	Sep 27	Option Exercise	5.95	3,460	20,587	6,144	Sep 29 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:04 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Sale	234.61	7,501	1,759,833	2,546	Sep 29 05:04 PM
Glenn Gregory M	President, R&D	Sep 27	Sale	234.43	2,083	488,315	4,061	Sep 29 05:08 PM
MOTT DAVID M	Director	Sep 23	Sale	252.90	24,961	6,312,616	40,000	Sep 24 05:10 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 21	Sale	227.37	7,500	1,705,265	718	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Option Exercise	19.08	7,500	143,100	8,218	Sep 22 05:05 PM
Trizzino John	EVP, CCO and CBO	Sep 20	Sale	227.57	7,500	1,706,748	718	Sep 22 05:05 PM
Glenn Gregory M	President, R&D	Sep 15	Option Exercise	37.90	1,183	44,832	5,244	Sep 17 05:08 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Option Exercise	19.08	5,000	95,400	5,706	Sep 17 05:11 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Sale	229.44	5,000	1,147,193	706	Sep 17 05:11 PM
Glenn Gregory M	President, R&D	Sep 15	Sale	229.34	1,183	271,304	4,061	Sep 17 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Sale	236.61	7,499	1,774,360	718	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Sale	235.29	7,499	1,764,433	718	Sep 15 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Option Exercise	19.08	5,000	95,400	5,706	Sep 03 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Sale	247.97	5,000	1,239,867	706	Sep 03 05:10 PM
Glenn Gregory M	President, R&D	Aug 31	Sale	239.87	1,386	332,463	4,061	Sep 01 05:23 PM
Glenn Gregory M	President, R&D	Aug 26	Option Exercise	5.95	6,921	41,180	8,228	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 26	Sale	233.92	4,167	974,740	4,061	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 16	Option Exercise	40.64	1,866	75,826	5,927	Aug 18 05:26 PM
Glenn Gregory M	President, R&D	Aug 16	Sale	233.52	1,866	435,750	4,061	Aug 18 05:26 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Option Exercise	14.83	2,896	42,960	3,602	Jul 28 05:00 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Sale	197.74	2,896	572,648	706	Jul 28 05:00 PM
Glenn Gregory M	President, R&D	Jul 20	Sale	215.43	2,409	518,982	2,811	Jul 22 05:20 PM
Glenn Gregory M	President, R&D	Jul 15	Option Exercise	13.08	10,477	137,006	8,465	Jul 19 07:52 PM
Glenn Gregory M	President, R&D	Jul 15	Sale	179.45	5,654	1,014,597	2,811	Jul 19 07:52 PM
Erck Stanley C	President and CEO	Jul 02	Option Exercise	80.66	52,559	4,239,511	73,054	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 02	Sale	215.89	52,559	11,347,066	20,495	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Option Exercise	61.59	52,620	3,240,965	73,115	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Sale	212.88	52,620	11,201,513	20,495	Jul 06 05:03 PM
Glenn Gregory M	President, R&D	Jun 17	Sale	183.28	2,411	441,887	2,811	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Option Exercise	13.16	10,535	138,685	8,527	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Sale	191.42	5,716	1,094,130	2,811	Jun 17 06:17 PM
EVANS GARY C	Director	Jun 01	Sale	146.50	625	91,562	0	Jun 03 05:34 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Option Exercise	14.83	2,895	42,932	3,170	Jun 02 04:59 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Sale	149.14	2,895	431,748	275	Jun 02 04:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience